Literature DB >> 1865366

Presystemic and systemic chiral inversion of R-(-)-fenoprofen in the rat.

B W Berry1, F Jamali.   

Abstract

Fenoprofen (FN), a member of the 2-arylpropionic acid (2-APA) class of nonsteroidal anti-inflammatory drugs is administered clinically as a racemate. In humans, FN has been shown to rapidly undergo substantial in vivo unidirectional chiral inversion with the inactive R-isomer converted to its active antipode. As with any p.o. administered drug, before reaching the systemic circulation. FN may undergo first-pass metabolism, the major organs involved being the gastrointestinal tract and/or the liver. The site(s) of inversion for the 2-APAs have been a subject of debate, with presystemic intestinal metabolism in humans and hepatic systemic metabolism in rats receiving the most attention. The inversion of R-FN was studied in the male Sprague-Dawley rat 1) in vivo after p.o. and i.v. administration of racemic-FN and R-FN, 2) after perfusion of R-FN into isolated liver (single-pass and recirculation) and 3) after a 2-hr incubation with everted intestinal tissue (duodenum, jejunum, ileum and colon) and noneverted stomach pouch. The enantiomers and their acyl-glucuronides were quantitated using a previously developed stereospecific assay. With the isolated liver, R-FN was shown to invert in both the single-pass and recirculation systems, with a first-pass extraction ratio of 0.3. A significant but variable inversion in all intestinal segments was observed. Substantial inversion by the duodenum was observed (serosal S:R ratio, 1.2) with maximal inversion by the jejunum (serosal S:R ratio, 2.2), whereas inversion of R-FN was absent in the stomach. Considerable glucuronidation was observed in all tissues studied including first-pass glucuronidation of both enantiomers after single-pass perfusion through the isolated liver and stereoselective glucuronidation in intestinal tissue segments. The results indicate that, in the male Sprague-Dawley rat, R-FN undergoes presystemic inversion by both the gastrointestinal tract and liver. These results, however, must be viewed with caution as they may not necessarily be extrapolated to other 2-APAs or species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865366

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs.

Authors:  L Montoya; L Ambros; V Kreil; R Bonafine; G Albarellos; R Hallu; A Soraci
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

3.  Chiral inversion of (R)-(-)-fenoprofen in guinea-pigs pretreated with clofibrate.

Authors:  M F San Martín; A Soraci; F Fogel; O Tapia; S Islas
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

4.  Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs.

Authors:  Katja Mustonen; Anneli Niemi; Marja Raekallio; Mari Heinonen; Olli At Peltoniemi; Mari Palviainen; Mia Siven; Marikki Peltoniemi; Outi Vainio
Journal:  Acta Vet Scand       Date:  2012-09-21       Impact factor: 1.695

5.  Involvement of the rat gut epithelial and muscular layer, and microflora in chiral inversion and acyl-glucuronidation of R-fenoprofen.

Authors:  S Sattari; F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Apr-Jun       Impact factor: 2.569

6.  Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.

Authors:  Waheed Asghar; Elliot Pittman; Fakhreddin Jamali
Journal:  Daru       Date:  2015-11-14       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.